Former OBIO CAAP company CellAegis Devices, has announced $9.5 Million US financing to support clinical and regulatory advancement of their autoRIC® Device.
This device automatically delivers Remote Ischemic Conditioning (RIC) to provide a non-invasive, cardio-protective therapy shown to reduce heart damage during heart attacks and other cardiovascular procedures.
Read the full Press Release HERE